https://merdury.com/wp-content/uploads/2022/02/Merdury_News4.png
958
1160
staging
/wp-content/uploads/2024/12/MERDURY-logo-1.png
staging2022-02-07 14:02:092025-05-19 15:19:13水星生醫首創Sildenafil薄荷口溶錠通過生物相等性人體試驗，積極準備申請多國藥證
https://merdury.com/wp-content/uploads/2022/02/image-8.jpg
1000
1500
staging
/wp-content/uploads/2024/12/MERDURY-logo-1.png
staging2022-02-07 14:01:402025-04-15 13:46:14公告水星生醫Stackdose平台獲國家藥科獎銅質獎
https://merdury.com/wp-content/uploads/2024/12/image-3.jpg
1001
1500
staging
/wp-content/uploads/2024/12/MERDURY-logo-1.png
staging2022-02-07 14:01:012025-04-15 13:47:53公告水星生醫*取得科技事業核准函，啟動IPO計畫，搶全球重磅藥市場
https://merdury.com/wp-content/uploads/2024/12/image-2.jpg
1217
1920
staging
/wp-content/uploads/2024/12/MERDURY-logo-1.png
staging2022-02-07 14:00:312025-04-15 13:49:54水星生醫*開發減重口服藥GLP-1致效劑（Semaglutide）獲顯著成果 並與智抗糖簽訂MOU 進行臨床試驗
https://merdury.com/wp-content/uploads/2024/12/image-1.jpg
1001
1500
staging
/wp-content/uploads/2024/12/MERDURY-logo-1.png
staging2022-02-07 13:59:592025-04-15 13:50:54水星生醫*治療DMD新藥 獲美國FDA孤兒藥資格
/wp-content/uploads/2024/12/MERDURY-logo-1.png
0
0
andrea
/wp-content/uploads/2024/12/MERDURY-logo-1.png
andrea2022-01-20 13:21:222025-04-22 13:43:45水星生醫*與旭富製藥簽訂MTA 開發抗癲癇藥物 StackDose™平台發揮加值藥物優勢
https://merdury.com/wp-content/uploads/2025/04/Merdury_News2.jpg
994
1477
andrea
/wp-content/uploads/2024/12/MERDURY-logo-1.png
andrea2022-01-19 13:38:142025-04-22 13:43:38水星生醫*受邀參加Berkely Public Health & J.P.Morgan等共同舉辦之「Healthcare Conference Taipei 2024」
https://merdury.com/wp-content/uploads/2022/01/Merdury_News3.png
674
680
andrea
/wp-content/uploads/2024/12/MERDURY-logo-1.png
andrea2022-01-18 13:44:282025-04-22 14:32:55求職徵才防詐騙重要聲明
/wp-content/uploads/2024/12/MERDURY-logo-1.png
0
0
andrea
/wp-content/uploads/2024/12/MERDURY-logo-1.png
andrea2022-01-17 13:47:462025-04-22 13:49:17水星生醫*治療DMD新藥 向美國FDA送件申請孤兒藥資格審查
/wp-content/uploads/2024/12/MERDURY-logo-1.png
0
0
andrea
/wp-content/uploads/2024/12/MERDURY-logo-1.png
andrea2022-01-16 13:49:572025-04-22 13:52:17水星生醫*與旭能醫藥簽訂技術平台授權與委託開發協議書 開發全球首顆治療ED和PE複方口溶錠
Scroll to top
